
Chief executive promotion at myoscience
pharmafile | November 10, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | jeffrey gold, myoscience
Californian medical device firm myoscience has appointed Jeffrey Gold as its chief executive.
Gold who was the president and chief operating officer (COO) at the firm, previously held posts as chief executive for Velomedix and CryoVascular Systems – as well as COO for CardioThoracic Systems.
Rich Ferrari who is executive chairman at myoscience, says: “I am very pleased to handover the role of chief executive to Jeff Gold. Jeff is a seasoned executive with a solid record of success. The myoscience board of directors fully supports the appointment and we are excited to have Jeff accept the leadership role as chief executive.”
“I am very excited to assume the responsibility of guiding myoscience through its next development stage,” adds Gold. “We have a strong team of dedicated professionals that will drive myoscience to greater success in the future.”






